TALL Trademark

Trademark Overview

On Monday, May 3, 2021, a trademark application was filed for TALL with the United States Patent and Trademark Office. The USPTO has given the TALL trademark a serial number of 90688104. The federal status of this trademark filing is REGISTERED as of Tuesday, March 5, 2024. This trademark is owned by SRI International. The TALL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and pharmacological research services in the field of immunotherapy and cancer treatment; biological research, clinical research, and medical research all in the field of immunotherapies and cancer treatment; development of drug delivery agents being made from liposomes and peptides; development of drug delivery agents that facilitate the delivery of pharmaceuticals and pharmaceutical preparations
tall

General Information

Serial Number90688104
Word MarkTALL
Filing DateMonday, May 3, 2021
Status700 - REGISTERED
Status DateTuesday, March 5, 2024
Registration Number7323222
Registration DateTuesday, March 5, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 15, 2022

Trademark Statements

Goods and ServicesMedical and pharmacological research services in the field of immunotherapy and cancer treatment; biological research, clinical research, and medical research all in the field of immunotherapies and cancer treatment; development of drug delivery agents being made from liposomes and peptides; development of drug delivery agents that facilitate the delivery of pharmaceuticals and pharmaceutical preparations

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 5, 2021
Primary Code042
First Use Anywhere DateSaturday, November 9, 2019
First Use In Commerce DateSaturday, November 9, 2019

Trademark Owner History

Party NameSRI International
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressMenlo Park, CA 94025
Party NameSRI International
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressMenlo Park, CA 94025
Party NameSRI International
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressMenlo Park, CA 94025

Trademark Events

Event DateEvent Description
Tuesday, March 5, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 5, 2024REGISTERED-PRINCIPAL REGISTER
Saturday, January 27, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, January 26, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, January 26, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 25, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 25, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 25, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 25, 2023NON-FINAL ACTION E-MAILED
Wednesday, October 25, 2023SU - NON-FINAL ACTION - WRITTEN
Wednesday, October 25, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, October 12, 2023USE AMENDMENT FILED
Wednesday, October 25, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 12, 2023TEAS STATEMENT OF USE RECEIVED
Friday, April 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 12, 2023SOU EXTENSION 2 GRANTED
Wednesday, April 12, 2023SOU EXTENSION 2 FILED
Wednesday, April 12, 2023SOU TEAS EXTENSION RECEIVED
Thursday, September 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 27, 2022SOU EXTENSION 1 GRANTED
Tuesday, September 27, 2022SOU EXTENSION 1 FILED
Tuesday, September 27, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, April 12, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 15, 2022PUBLISHED FOR OPPOSITION
Wednesday, January 26, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 12, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 12, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, January 12, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, January 12, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, January 12, 2022EXAMINERS AMENDMENT -WRITTEN
Tuesday, January 4, 2022ASSIGNED TO EXAMINER
Thursday, August 5, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 6, 2021NEW APPLICATION ENTERED

Related Keywords

tall research delivery medical drug agents treatment development field cancer peptides